We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+28.76%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$12.4B
AUM Growth
+$2.29B
Cap. Flow
-$8.07M
Cap. Flow %
-0.07%
Top 10 Hldgs %
9.07%
Holding
848
New
74
Increased
361
Reduced
233
Closed
101
Avg Time Held
18.2 quarters
Top 10 Avg Time Held
3.2 quarters
Top 20 Avg Time Held
7.1 quarters

Top Buys

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$43.3M
2
MSA icon
Mine Safety
MSA
+$37.1M
3
YSWY icon
Yesway Inc
YSWY
+$34.7M
4
DORM icon
Dorman Products
DORM
+$24.6M
5
AVTR icon
Avantor
AVTR
+$19M

Top Sells

Rank Stock Value
1
COHU icon
Cohu
COHU
+$54.5M
2
CPRX icon
Catalyst Pharmaceutical
CPRX
+$51.1M
3
MKSI icon
MKS Inc
MKSI
+$44.5M
4
VSH icon
Vishay Intertechnology
VSH
+$40.2M
5
LFUS icon
Littelfuse
LFUS
+$35.4M

Sector Composition

Rank Sector Weight
1 Industrials 26.88%
2 Technology 19.45%
3 Financials 14.84%
4 Consumer Discretionary 12.86%
5 Healthcare 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MIAX icon
251
Miami International Holdings
MIAX
$2.98B
$16.8M 0.14%
452,813
+143,537
+46% +$6.42M
2025 Q4
2 quarters
HRI icon
252
Herc Holdings
HRI
$4.25B
$16.8M 0.14%
+116,999
New +$15.1M
2026 Q2
0 quarters
RNR icon
253
RenaissanceRe
RNR
$14.1B
$16.6M 0.13%
53,220
-11,748
-18% -$3.53M
2020 Q2
24 quarters
STVN icon
254
Stevanato
STVN
$5.25B
$16.6M 0.13%
916,356
+75,030
+9% +$1.27M
2022 Q1
17 quarters
SRTA icon
255
Strata Critical Medical Inc
SRTA
$402M
$16.5M 0.13%
3,132,933
+316,561
+11% +$1.67M
2024 Q4
6 quarters
PLOW icon
256
Douglas Dynamics
PLOW
$908M
$16.5M 0.13%
305,292
+106,044
+53% +$4.89M
2025 Q2
4 quarters
CDNA icon
257
CareDx
CDNA
$3.27B
$16.4M 0.13%
575,971
+22,774
+4% +$496K
2014 Q4
46 quarters
ECPG icon
258
Encore Capital Group
ECPG
$2.14B
$16.3M 0.13%
175,020
-34,590
-17% -$2.82M
2021 Q3
19 quarters
AEBI icon
259
Aebi Schmidt Holding AG
AEBI
$857M
$16.3M 0.13%
1,300,146
+40,180
+3% +$475K
2025 Q3
3 quarters
CRI icon
260
Carter's
CRI
$1.18B
$16.3M 0.13%
396,381
+67,508
+21% +$2.55M
2025 Q1
5 quarters
BBIO icon
261
BridgeBio Pharma
BBIO
$12.9B
$16.3M 0.13%
218,487
-14,436
-6% -$1.01M
2024 Q3
7 quarters
JJSF icon
262
J&J Snack Foods
JJSF
$1.5B
$16.2M 0.13%
221,151
-253,540
-53% -$19.7M
2025 Q4
2 quarters
VRNS icon
263
Varonis Systems
VRNS
$5.33B
$16.1M 0.13%
+384,416
New +$11.3M
2026 Q2
0 quarters
NTGR icon
264
NETGEAR
NTGR
$627M
$16.1M 0.13%
687,977
+312,362
+83% +$7.77M
2025 Q4
2 quarters
COO icon
265
Cooper Companies
COO
$10.6B
$16.1M 0.13%
+223,879
New +$14.6M
2026 Q2
0 quarters
PRIM icon
266
Primoris Services
PRIM
$4.46B
$16M 0.13%
161,736
+65,686
+68% +$8.64M
2019 Q2
28 quarters
STRZ icon
267
Starz Entertainment Corp
STRZ
$425M
$16M 0.13%
552,811
+40,360
+8% +$879K
2025 Q2
4 quarters
VPG icon
268
Vishay Precision Group
VPG
$922M
$15.9M 0.13%
106,209
-299,464
-74% -$27.8M
2013 Q2
52 quarters
LPTH icon
269
Lightpath Technologies
LPTH
$618M
$15.9M 0.13%
969,621
-20,000
-2% -$279K
2016 Q4
38 quarters
RXO icon
270
RXO
RXO
$4.73B
$15.8M 0.13%
573,220
+110,220
+24% +$2.43M
2025 Q4
2 quarters
CON icon
271
Concentra Group Holdings
CON
$4.79B
$15.7M 0.13%
527,852
+40,720
+8% +$1.01M
2024 Q4
6 quarters
DCO icon
272
Ducommun
DCO
$2.55B
$15.7M 0.13%
84,741
+160
+0.2% +$23.7K
2013 Q2
52 quarters
NGS icon
273
Natural Gas Services Group
NGS
$424M
$15.7M 0.13%
363,319
+10,003
+3% +$407K
2013 Q2
52 quarters
CVLG icon
274
Covenant Logistics
CVLG
$808M
$15.7M 0.13%
354,647
+12,779
+4% +$466K
2024 Q2
8 quarters
CBC icon
275
Central Bancompany Inc
CBC
$7.8B
$15.6M 0.13%
+514,112
New +$14M
2026 Q2
0 quarters

Similar funds

Royce & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, Royce & Associates held 848 positions worth $12.4B, up 23% from $10.1B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Royce & Associates's Q2 2026 filing shows 74 new, 361 increased, 233 reduced and 101 closed positions. Its largest new stake was Manhattan Associates: 314,304 shares worth $43.8M. The largest sale was Cohu, an estimated $54.5M.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q2 2026 buy was Manhattan Associates: 314,304 shares worth $43.8M.
  • Royce & Associates added most to Mine Safety in Q2 2026, an estimated $37.1M increase.
  • Royce & Associates's biggest Q2 2026 reduction was Cohu, cutting an estimated $54.5M.
  • Royce & Associates fully exited Transmedics in Q2 2026, selling an estimated $24.3M.
  • Royce & Associates's ten largest holdings make up 9.1% of its $12.4B portfolio in Q2 2026.
  • Royce & Associates opened 74 new positions and closed 101 in Q2 2026.
  • Royce & Associates's portfolio value rose 23% quarter-over-quarter to $12.4B.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.